March 31th, 2008

[past headlines]

Thallion delays trial of new E. coli drug Toronto Star - Ontario, Canada MONTREAL-Thallion Pharmaceuticals Inc. is delaying the Phase 2/3 clinical trial of Shigamabs, a treatment for Shiga-toxin E. coli food-borne bacterial ...